Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Thioquinoline Derivatives Conjugated to Thiosemicarbazide As Potent Tyrosinase Inhibitors With Anti-Melanogenesis Properties Publisher Pubmed



Noori M1 ; Sabourian R2 ; Tasharoie A2 ; Safavi M3 ; Iraji A4, 5 ; Khalili Ghomi M1 ; Dastyafteh N1 ; Irajie C6 ; Zarenezhad E4 ; Mostafavi Pour SM7 ; Rasekh F8 ; Larijani B1 ; Amini M9 ; Hajimahmoodi M2, 10 Show All Authors
Authors
  1. Noori M1
  2. Sabourian R2
  3. Tasharoie A2
  4. Safavi M3
  5. Iraji A4, 5
  6. Khalili Ghomi M1
  7. Dastyafteh N1
  8. Irajie C6
  9. Zarenezhad E4
  10. Mostafavi Pour SM7
  11. Rasekh F8
  12. Larijani B1
  13. Amini M9
  14. Hajimahmoodi M2, 10
  15. Mahdavi M1
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Drug and Food Control Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Biotechnology, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran
  4. 4. Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
  7. 7. Liosa Pharmed Parseh Company, Shiraz, Iran
  8. 8. Department of Biology, Payame Noor University(PNU), Tehran, Iran
  9. 9. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Halal Research Center of IRI, Food and Drug Administration, Ministry of Health and Medical Education, Tehran, Iran

Source: Scientific Reports Published:2023


Abstract

In the present study, a series of aryl-substituted thioqunoline conjugated to thiosemicarbazide were rationally designed and synthesized. The formation of target compounds was confirmed by spectral characterization techniques such as IR, 1H-NMR, 13C-NMR, ESI–MS, and elemental analysis. Among the synthesized derivatives, compound 10g bearing para-chlorophenyl moiety was proved to be the most potent tyrosinase inhibitor with an IC50 value of 25.75 ± 0.19 µM. Compound 10g as the most potent derivative exhibited a noncompetitive inhibition pattern against tyrosinase in the kinetic study. Furthermore, the in silico cavity detection, as well as the molecular docking assessments, were performed to follow the behavior of 10g within the proposed binding site. Besides, the toxicity of 10g and its potency to reduce the melanin content on A375 cell lines were also measured. Consequently, aryl-substituted thioqunolines conjugated to thiosemicarbazide might be a promising candidate in the cosmetics, medicine, and food industry as tyrosinase inhibitors. © 2023, The Author(s).
Experts (# of related papers)
Other Related Docs